OWKIN in den Nachrichten
KI-Plattform für biologische Entdeckungen
Tamtam hat 20 aktuelle Artikel über OWKIN gefunden.
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Owkin: Pioneering Biological Artificial Superintelligence for the Future of Medicine
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
- Sanofi expands AI ambitions through new Owkin collaboration
- Owkin and Sanofi Expand Partnership to Develop AI Agents Through K Pro Collaboration
- Sanofi and Owkin partner to develop next-generation biopharma AI agents
- Sanofi Owkin AI Deal Puts R&D Shift And Valuation In Focus
- Owkin To Build AI Agents As Part Of A Multi-Year K Pro Collaboration With Sanofi
- Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sanofi (NASDAQ:SNY)
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
- Owkin, Sanofi expand AI collaboration to build drug development AI agents
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
- Why AI models need patient data to deliver in drug discovery
- OWKIN Showcases AI-Driven Trial De-Risking Capabilities at Harvard Symposium
- OWKIN Highlights AI Metric Choice to Improve Oncology Target Discovery
- OWKIN Deepens U.K. Data Network and Sharpens AI Biology Strategy Amid Sector Funding Shifts
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie OWKIN?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden